A new 30-gene signature has been described that separates prostate cancers of Gleason score {less than or equal to} 6 from those of Gleason score {greater than or equal to} 8. It provides independent prognostic information for prostate cancers of intermediate risk (Gleason score of 7) which has the potential to stratify these patients into different risk groups.
from Cancer via ola Kala on Inoreader http://ift.tt/2fceBWT
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου